×
  • Catégorie
  • Type
  • Advanced

Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19

Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19

Interim recommendations for heterologous COVID-19 vaccine schedules

Mini-cPIE Clinic #05: Inequities in vaccine uptake and gender considerations (Pdf slide deck)

Planning considerations for human and financial resources for COVID-19 vaccination

Data Sharing Protocol

Core Principles

Country Deployment Brief

Verification and Traceability Initiative 2 Page Brief

Verification and Traceability Initiative Overview

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 15: COVID-19 and COVAX Data, Country, Regional, Global Views

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 16: COVID-19 Vaccines Impact Modelling - Key Issues to know about Modeled Evidence to Inform Prioritization and Delivery

Annexes to the interim recommendations for use of the Janssen Ad26.COV2.S vaccine

COVID-19 vaccine implementation job aid: Early challenges and locally identified solutions

Q&A for Mini-cPIE Clinic #03: Country Experience Sharing and Lessons Learned from Fragile States/Humanitarian Contexts

Q&A for Mini-cPIE Clinic #02: Country Experience Sharing and Lessons Learned

Mini-cPIE Clinic #04: Promoting COVID-19 Vaccine Uptake - Unique Risk Communication and Community Engagement Approaches (Pdf slide deck)

Q&A for Mini-cPIE Clinic #04: Promoting COVID-19 Vaccine Uptake - Unique Risk Communication and Community Engagement Approaches

Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19